Rising Pharmaceuticals has voluntarily recalled over 233,000 bottles of Duloxetine in the US due to potential contamination with N-nitroso-duloxetine, a probable carcinogen. The FDA classified the recall as Class II, posing a potential, though remote, risk of adverse health effects. The recall affects 30, 90, and 1000-count bottles of 60mg capsules with specific lot numbers and expiration dates. Rising Pharmaceuticals has voluntarily recalled over 233,000 bottles of Duloxetine in the US due to potential contamination with N-nitroso-duloxetine, a probable carcinogen. The FDA classified the recall as Class II, posing a potential, though remote, risk of adverse health effects. The recall affects 30, 90, and 1000-count bottles of 60mg capsules with specific lot numbers and expiration dates. Health and Fitness, Health Tips, Exercises & Workout Tips, Diet & Wellness | Times of India Lifestyle
